Riskpilot← Back to searchSign inGet full accessCYTOTRACK ApS
APSBankruptCVR 27513298Gammel Lundtoftevej 1D, st.Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 20041 employees
Revenue 2020
DKK 979K
-36% vs 2019
EBITDA margin
-76.6%
-398% vs 2019
Equity ratio
-21.0%
Financial strength
Net profit 2020
DKK -789K
-455% vs 2019
| Revenue | DKK 979K | -36% |
| EBITDA | DKK -750K | -398% |
| Net profit | DKK -789K | -455% |
| Total assets | DKK 4,2M | +12% |
| Equity | DKK -874K | -930% |
| Employees | 1 | — |
Legal name
CYTOTRACK ApS
CVR number
27513298
Legal form
Anpartsselskab
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
3. juni 2004
Share capital
DKK 228.514
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer eller af selskabets direktør og bestyrelsesformanden i forening
Address
Gammel Lundtoftevej 1D, st.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | -1.171 | 4.975 | 4.228 | 2.558 | -224 | -461 | 1.523 | 979 |
| Staff expenses | -0 | -35 | -4.214 | -4.141 | -2.346 | -466 | -0 | -1.272 | -1.729 |
| EBITDA | -1.295 | -1.206 | 761 | 87 | 211 | -690 | -461 | 251 | -750 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1.295 | -1.206 | 761 | 87 | 211 | -690 | -461 | 251 | -750 |
| Net financials | 0 | -7 | -10 | -43 | -18 | -19 | -17 | -29 | -39 |
| Profit before tax | -1.295 | -1.213 | 751 | 43 | 193 | -710 | -478 | 223 | -789 |
| Tax | -0 | -0 | -0 | -0 | -176 | -0 | -81 | -0 | -0 |
| Net profit | -1.295 | -1.213 | 751 | 43 | 369 | -710 | -397 | 223 | -789 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 64 | 7.341 | 2.454 | 2.163 | 4.269 | 485 | 5.943 | 3.713 | 4.154 |
| Equity | -9.733 | -10.946 | 387 | 430 | 799 | 89 | -307 | -85 | -874 |
| Long-term debt | 9.610 | 0 | 0 | 700 | 0 | 0 | 0 | 30 | 0 |
| Short-term debt | 187 | 7.705 | 2.067 | 1.033 | 3.470 | 396 | 6.251 | 3.768 | 5.028 |
| Total debt | 9.797 | 7.705 | 2.067 | 1.733 | 3.470 | 396 | 6.251 | 3.798 | 5.028 |
EBITDA margin
-76.6%
This company
15.8%
Market median
-585% vs market
20122020
Equity ratio
-21.0%
This company
38.2%
Market median
-155% vs market
20122020
Return on equity
-78917700.0%
This company
18.4%
Market median
-428900643% vs market
20122020
Net profit margin
-80.6%
This company
8.1%
Market median
-1095% vs market
20122020
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20122020
Debt / equity
5.75×
This company
0.62×
Market median
-827% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Management | Management | 2004 | — | — |
OS Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
2C A/S | Company | 15.0% | 15.0% | 2013 |
LARS ULRIK NIELSEN ApS | Company | 20.0% | 20.0% | 2013 |
2C FINANCE ApS | Company | 33.3% | 33.3% | 2013 |
JKJJ HOLDING ApS | Company | 15.0% | 15.0% | 2019 |
NIMBUS TEKNOLOGI ApS | Company | 20.0% | 20.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CYTOTRACK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Hede Markussen | Management | 0 companies |
| Ole Strange | Chief Executive Officer | 0 companies |
| Lars Marcus Pedersen | Chairman | 0 companies |
| Nils Aage Brünner | Board of Directors | 0 companies |
| Ole Bitsch-Jensen | Chairman | 0 companies |
| Lars Ulrik Nielsen | Board of Directors | 0 companies |
| Christian Caspersen | Board of Directors | 0 companies |
| Sten Verland | Chairman | 0 companies |